Close Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Hold |
495
| – | – | ﹤0.01% | 189 |
|
|
2025
Q1 | $35K | Hold |
495
| – | – | ﹤0.01% | 167 |
|
|
2024
Q4 | $33K | Hold |
495
| – | – | ﹤0.01% | 166 |
|
|
2024
Q3 | $35K | Hold |
495
| – | – | ﹤0.01% | 178 |
|
|
2024
Q2 | $41K | Buy |
+495
| New | +$41K | ﹤0.01% | 167 |
|
|
2022
Q4 | – | Sell |
-5
| Closed | – | – | 197 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 185 |
|
|
2022
Q2 | $0 | Sell |
5
-645
| -99% | – | ﹤0.01% | 190 |
|
|
2022
Q1 | $57K | Hold |
650
| – | – | ﹤0.01% | 119 |
|
|
2021
Q4 | $57K | Hold |
650
| – | – | ﹤0.01% | 119 |
|
|
2021
Q3 | $50K | Buy |
650
+648
| +32,400% | +$49.8K | ﹤0.01% | 122 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 202 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 215 |
|